Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
STO-609
Cat. No.:
OB0225LY-0496
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
STO-609 is a small molecule inhibitor that specifically targets Ca2+/calmodulin-dependent protein kinase (CaMK). It has important applications in cell signaling and biopharmacological studies.
Synonym:
STO 609; 52029-86-4; STO609; 7-oxo-7H-Benzimidazo[2,1-A]benz[de]isoquinoline-3-carboxylic acid; 7-oxo-7H-Benzo[de]benzo[4,5]imidazo[2,1-a]isoquinoline-3-carboxylic acid; 7H-Benzimidazo(2,1-a)benz(de)isoquinoline-7-one-3-carboxylic acid
CAS No.:
52029-86-4
Compound CID:
3467590
Formula:
C19H10N2O3
Formula Weight:
314.29
Specification
Relative Density:
1.54 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
STO-609 can be used to study neuronal signaling or play an important role in the study of mechanisms related to cardiovascular disease.
Library Information
Targets:
Kinases
Receptors:
AMPK; CaM-KKα; CaM-KKβ; CaMK
Pathways:
Neuronal signaling; Autophagy; PI3K/Akt/mTOR signaling; Chromatin/Epigenetic
Plate Number:
AOCL-7
Plate Location:
d8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
4.17 mg/mL; 13.26 mM
